Clifford Chance has advised CITIC Securities (Hong Kong) Limited and ABCI Securities Company Limited as joint sponsors. O’Melveny has represented TenNor Therapeutics (Suzhou) Limited. TenNor Therapeutics...
TenNor Therapeutics Raises HK$627 Million in Hong Kong Stock Exchange IPO
Metis TechBio Completes HK$2.1 Billion IPO on Hong Kong Stock Exchange
O’Melveny has advised the joint sponsors, overall coordinators and other underwriters. Metis TechBio Co., Ltd. has successfully completed its initial public offering and debut listing on...
Cofoe Medical Completes HK$1.062 Billion Listing on the Hong Kong Stock Exchange
O’Melveny & Myers has advised Cofoe Medical Technology Co., Ltd. on its Hong Kong Stock Exchange listing. Cofoe Medical Technology Co., Ltd. has completed its listing...
Diagens Completes HK$790 Million Initial Public Offering on Hong Kong Stock Exchange
O’Melveny has advised Hangzhou Diagens Biotechnology Co., Ltd. in its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. Hangzhou...
Shenzhen Woer Heat-Shrinkable Material Lists on Hong Kong Stock Exchange in HK$2.84 Billion Offering
O’Melveny & Myers LLP has advised Shenzhen Woer Heat-Shrinkable Material Co., Ltd. on its listing on the Main Board of the Hong Kong Stock Exchange. Shenzhen...
Ribo Life Science Completes HK$1.83 Billion Hong Kong IPO
Kirkland & Ellis has advised Suzhou Ribo Life Science Co., Ltd. on its global offering and listing. O’Melveny & Myers has represented the joint sponsors CICC...
TransThera Sciences Completes HK$190 Million Placement of New H Shares
O’Melveny & Myers has advised TransThera Sciences (Nanjing), Inc. TransThera Sciences (Nanjing), Inc. has completed the placement of 2,100,000 new H shares under a general mandate,...
Vigonvita Life Sciences Completes HK$600 Million IPO on Hong Kong Stock Exchange
O’Melveny has advised Vigonvita Life Sciences Co., Ltd. Vigonvita Life Sciences Co., Ltd. has completed its initial public offering and listing on the Main Board of...
CNGR Advanced Material Completes US$450 Million A+H Share Listing on Hong Kong Stock Exchange
O’Melveny has advised the joint sponsors and underwriters. CNGR Advanced Material Co., Ltd. has completed its A+H share listing on the Main Board of the Hong...
Shuangdeng Group Debuts on Hong Kong Stock Exchange with HK$850 Million IPO
O’Melveny has advised Shuangdeng Group. Latham & Watkins has advised CICC, Huatai International, and CCBI. Shuangdeng Group Co., Ltd. has completed its initial public offering (IPO)...
TransThera Sciences Completes HK$200 Million H-Share IPO on Hong Kong Exchange
O’Melveny has advised TransThera Sciences (Nanjing), Inc. Sidley has advised joint sponsors CITIC Securities (Hong Kong) Limited and Huatai Financial Holdings (Hong Kong) Limited, and the...
Shouhui Group Completes HK$196.8 Million Hong Kong IPO
O’Melveny has advised the underwriters on the IPO. Shouhui Group Limited has successfully completed its initial public offering on the Main Board of the Hong Kong...